Streetbeat News

Stock Prices

SYRS

Syros Pharmaceuticals (NASDAQ:SYRS) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $-1.13. The company's past performance shows a pattern of share price changes following earnings reports. The stock is currently trading at $3.65, down 61.07% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 7:01 pm

AVIR

Atea Pharmaceuticals (NASDAQ:AVIR) is set to release its latest quarterly earnings report on August 8, 2023. Analysts estimate an earnings per share (EPS) of $-0.47. The company's past performance shows a trend of beating EPS estimates but experiencing a drop in share price. The stock is currently trading at $3.47, down 59.96% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 7:01 pm

CLX

Over the past 3 months, 4 analysts have published their opinion on Clorox (NYSE:CLX) stock, with 2 being indifferent and 2 somewhat bearish. The company has an average price target of $147.5, which has increased by 11.74% over the past month.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 7:00 pm

BNTX

MRNA

Moderna, Inc. (NASDAQ:MRNA) shares traded lower on Monday, possibly in sympathy with BioNTech (NASDAQ:BNTX), which reported a year-over-year drop in sales and reduced its R&D spending outlook for 2023. BioNTech's Q2 sales were €167.70 million ($207.94 million), a 94.75% decrease from the same period last year. Moderna's shares fell nearly 7% in response to BioNTech's earnings report.

Portfolio Pulse from Ryan Gustafson

August 07, 2023 | 7:00 pm

AMN

Analysts have provided various ratings for AMN Healthcare Services (NYSE:AMN) within the last quarter, with an average 12-month price target of $106.25, a decrease of 4.71% from the previous average price target of $111.50. The ratings are based on the company's predicted future earnings and the predictability of its revenue streams.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 7:00 pm

TJX

TJX Companies (NYSE:TJX) has received mostly bullish ratings from analysts in the last quarter, with an average price target of $94.67, an increase of 11.9% from the previous average price target of $84.60. The ratings are based on research of company financial statements, conference calls, meetings, and insider information.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 7:00 pm

SUM

Summit Materials (NYSE:SUM) has received various ratings from 10 analysts over the last quarter, with 5 bullish, 2 somewhat bullish, 2 indifferent, and 1 somewhat bearish. The average 12-month price target for the company, according to these analysts, is $42.8, which has increased by 16.72% over the past month.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 7:00 pm

WMS

In the last quarter, Advanced Drainage Systems (NYSE:WMS) received mostly bullish and somewhat bullish ratings from analysts. The company's average 12-month price target has increased by 10.93% from the previous average, now standing at $129.0 with a high of $162.00 and a low of $102.00.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 7:00 pm

OPUSD

Optimism's (CRYPTO: OP) price rose 4.64% to $1.78 in the past 24 hours, continuing its positive trend over the past week with a 6.0% gain. The coin's all-time high is $3.22. The trading volume for the coin has decreased 52.0% over the past week, while the overall circulating supply of the coin has increased 4.95% to over 716.71 million. The current market cap ranking for OP is #41 at $1.28 billion.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 7:00 pm

INTU

Over the last quarter, 14 analysts have provided ratings for Intuit (NASDAQ:INTU), with 7 being bullish, 6 somewhat bullish, and 1 indifferent. The average price target is $517.07, implying an upside from the current price of $503.17. The average price target has increased by 2.57% over the past month.

Portfolio Pulse from Benzinga Insights

August 07, 2023 | 7:00 pm